AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy

RecruitingNAAges 65 Years - anyAllLudwig-Maximilians - University of Munich
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The PARTNER study is a multicentre, two-arm, pragmatic cluster-randomised trial evaluating the impact of a focused and patient-centred cooperation between general practitioners (GPs) and community pharmacists (PARTNER intervention) on reductions in the use of psychotropic, sedative and anticholinergic potentially inappropriate medication (PSA-PIM) compared to a control intervention. The PARTNER intervention comprises (1) education for health care professionals, (2) an interprofessional workshop and case conference, (3) a pharmacy visit with brown bag/medication review and patient empowerment, (4) GP practice visit with shared decision making. The control intervention only comprises a pharmacy visit with brown bag review.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Aged 65 years or older * Patient is capable of giving consent * GP contact in the quarter prior to inclusion * Current use of โ‰ฅ 5 drugs, including โ‰ฅ 1 PSA-PIM (hypnotics, opioids, gabapentinoids, antipsychotics, antidepressants, anticholinergic urospasmolytics) with a treatment duration of โ‰ฅ 6 months * Willingness to select a regular pharmacy for the study period * Consent to data exchange between GP and community pharmacy Exclusion Criteria: * Terminal illness (life expectancy \< 6 months) * Current treatment of pain associated with cancer * Other serious physical illness or mental distress (e.g. bereavement) that makes participation in the study impossible (according to the GP's assessment) * Psychiatric illness or addiction that makes participation in the study impossible (according to the GP's assessment) * Unable to meet the requirements of the study (participation in telephone or written questionnaires, visits to the GP practice or community pharmacy, alone or with the help of caregivers for physical infirmity) * Current participation in research projects on medication safety or geriatric medicine
๐Ÿ’Š

What it tests

  • PARTNER intervention
  • Control intervention
๐Ÿ“

Where

3 sites
University of Bielefeld
Bielefeld, Germany
University Hospital, LMU Munich
Munich, Germany
Witten/Herdecke University
Witten, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy